Categories: News

Coloplast A/S – Q1 2023/24 Earnings Release – Invitation for conference call on 9 February 2024 at 11.00am CET

Friday, 9 February 2024 at 11.00 – 12.00 CET
In connection with the publication of Coloplast’s interim financial results for Q1 2023/24, to be released same day around 07.30 am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.

Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard  Executive Vice President, CFO
Aleksandra Dimovska – Senior Director, Investor Relations
Kristine Husted Munk – Senior Manager, Investor Relations

Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here


Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here

 

For more information, please contact:

Aleksandra Dimovska – Senior Director, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com

Kristine Husted Munk – Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266. E-mail: dkkhu@coloplast.com

Hannah K. Larsen – Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3616. E-mail: dkhakl@coloplast.com

 

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

Staff

Recent Posts

Dr. Todd H. Lanman Presented Alignment-Driven Synergy Disc(R) Results and Case Experience at the 2nd Annual Hoag Orthopedic Institute Spine Symposium

Synergy Disc® presentation showcased statistically superior IDE trial outcomes, restoration of cervical lordosis, and long-term…

5 hours ago

From Fusion to Motion: Dr. Joel S. Beckett Presented Restorative Motion Surgery Concepts at the Hoag Orthopedic Institute Spine Symposium

Presentation explored motion-restoring alternatives for select patients with persistent pain or pseudoarthrosis following cervical fusion…

5 hours ago

IAVI to Advance Vaccine Candidate for Bundibugyo Virus, Receives Funding from CEPI

WHO identifies rVSV-based candidate as a top priority amid growing Ebola epidemic with no approved…

5 hours ago

Medical Care Technologies (OTC PINK:MDCE) Provides Initial Overview of Melanoma Scan Beta User Experience and Interface Design

Company highlights streamlined body-map tracking and image management features designed to support long-term skin monitoring…

5 hours ago

Edison Issues Report on Nabaltec (NTG)

London, United Kingdom--(Newsfile Corp. - June 1, 2026) - Edison issues report on Nabaltec (XETRA:…

6 hours ago

Revelation Biosciences Expands Acute Kidney Injury Advisory Board

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB)…

8 hours ago